{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:54:07Z","timestamp":1792547647409,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jaip.2024.01.038","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T03:34:51Z","timestamp":1706844891000},"page":"1520-1529.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Sublingual Tablet Immunotherapy Improves Quality of Life in Adults With Allergic Rhinoconjunctivitis"],"prefix":"10.1016","volume":"12","author":[{"given":"Michael S.","family":"Blaiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stranzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian Funding","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.01.038_bib1","doi-asserted-by":"crossref","first-page":"e12130","DOI":"10.1002\/clt2.12130","article-title":"Worldwide prevalence of rhinitis in adults: a review of definitions and temporal evolution","volume":"12","author":"Savour\u00e9","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2024.01.038_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1710-1492-7-S1-S3","article-title":"Allergic rhinitis","volume":"7","author":"Small","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.amjoto.2007.06.002","article-title":"Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis","volume":"29","author":"Craig","year":"2008","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jaip.2024.01.038_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.31782\/IJCRR.2021.13204","article-title":"To study the impact of allergic rhinitis on quality of life in a tertiary care hospital","volume":"13","author":"Aruthra","year":"2021","journal-title":"IJCRR"},{"key":"10.1016\/j.jaip.2024.01.038_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1081-1206(10)62850-5","article-title":"Quality of life in allergic rhinitis","volume":"83","author":"Blaiss","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2500\/aap.2009.30.3230","article-title":"Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey","volume":"30","author":"Meltzer","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.01.038_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2500\/aap.2007.28.3013","article-title":"Allergic rhinoconjunctivitis: burden of disease","volume":"28","author":"Blaiss","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.01.038_bib8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/all.12470","article-title":"Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.01.038_bib9","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jaip.2017.09.002","article-title":"Impact of rhinitis on work productivity: a systematic review","volume":"6","author":"Vandenplas","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.01.038_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/14737167.2020.1819793","article-title":"Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy","volume":"20","author":"Dierick","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jaip.2024.01.038_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/npjpcrm.2015.82","article-title":"TOTALL: high cost of allergic rhinitis\u2014a national Swedish population-based questionnaire study","volume":"26","author":"Cardell","year":"2016","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaip.2024.01.038_bib12","article-title":"Allergic rhinitis: impact, diagnosis, treatment and management","volume":"8","author":"Church","year":"2016","journal-title":"Clin Pharm"},{"key":"10.1016\/j.jaip.2024.01.038_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13223-017-0208-7","article-title":"Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children","volume":"13","author":"Leger","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2222.1991.tb00807.x","article-title":"Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis","volume":"21","author":"Juniper","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.01.038_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anai.2013.11.018","article-title":"Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial","volume":"112","author":"Maloney","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults","volume":"127","author":"Nelson","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-5751-12-10","article-title":"A\u00a0phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma","volume":"12","author":"Murphy","year":"2013","journal-title":"J\u00a0Negat Results Biomed"},{"key":"10.1016\/j.jaip.2024.01.038_bib22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.anai.2013.03.013","article-title":"Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults","volume":"110","author":"Nolte","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib23","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2013.03.019","article-title":"Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults","volume":"131","author":"Creticos","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib24","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jaci.2018.12.1001","article-title":"The SQ tree SLIT-tablet is highly effective and well tolerated: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"143","author":"Biedermann","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaci.2015.06.036","article-title":"Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"137","author":"Demoly","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib26","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2016.06.044","article-title":"Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial","volume":"138","author":"Nolte","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib27","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jaci.2014.12.1911","article-title":"Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber","volume":"135","author":"Nolte","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib28","first-page":"391","article-title":"Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment","volume":"23","author":"Murray","year":"2002","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.01.038_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2500\/aap.2012.33.3571","article-title":"Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis","volume":"33","author":"Meltzer","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.01.038_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2500\/aap.2012.33.3593","article-title":"Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis","volume":"33","author":"van Bavel","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.01.038_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaip.2014.09.018","article-title":"Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy","volume":"3","author":"Nelson","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.01.038_bib32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2018.03.008","article-title":"The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases","volume":"67","author":"Nolte","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2024.01.038_bib33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaci.2011.06.022","article-title":"Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis","volume":"128","author":"Didier","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib34","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2020.07.036","article-title":"A\u00a0300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized phase III clinical trial","volume":"147","author":"Demoly","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/lary.29586","article-title":"Subcutaneous versus sublingual immunotherapy for adults with allergic rhinitis: a systematic review with meta-analyses","volume":"132","author":"Tie","year":"2022","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2024.01.038_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/19458924211050547","article-title":"Efficacy and safety of subcutaneous immunotherapy for local allergic rhinitis: a meta-analysis of randomized controlled trials","volume":"36","author":"Zhu","year":"2022","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2024.01.038_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jaci.2005.11.014","article-title":"Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis","volume":"117","author":"Frew","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib38","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1398-9995.2007.01455.x","article-title":"Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis","volume":"62","author":"Powell","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.01.038_bib39","first-page":"231","article-title":"Quality of life and compliance in patients allergic to grass and rye pollen: during a 3-year treatment with specific immunotherapy (the LQC study)","volume":"Supplement 2","author":"Bergmann","year":"2005","journal-title":"Allergy Clin Immunol Int"},{"key":"10.1016\/j.jaip.2024.01.038_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1179\/2042618612Y.0000000001","article-title":"Clinimetrics corner: a closer look at the minimal clinically important difference (MCID)","volume":"20","author":"Wright","year":"2012","journal-title":"J\u00a0Man Manip Ther"},{"key":"10.1016\/j.jaip.2024.01.038_bib41","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0091-6749(96)70135-5","article-title":"Interpretation of rhinoconjunctivitis quality of life questionnaire data","volume":"98","author":"Juniper","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","article-title":"Determining a minimal important change in a disease-specific quality of life questionnaire","volume":"47","author":"Juniper","year":"1994","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2024.01.038_bib43","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/all.15207","article-title":"Determining the minimal important differences in the RQLQ score with grass and tree allergy immunotherapy versus placebo in adults with moderate-to-severe allergy","volume":"77","author":"Blaiss","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.01.038_bib44","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.jaci.2004.08.044","article-title":"The correlation between allergic rhinitis and sleep disturbance","volume":"114","author":"Craig","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3132\/pcrj.2008.00001","article-title":"Allergic rhinitis-induced nasal congestion: its impact on sleep quality","volume":"17","author":"Storms","year":"2008","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaip.2024.01.038_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11882-012-0330-z","article-title":"Impact of sleep as a specific marker of quality of life in allergic rhinitis","volume":"13","author":"Gonz\u00e1lez-N\u00fa\u00f1ez","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2024.01.038_bib47","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1001\/archinte.166.16.1744","article-title":"Allergic rhinitis and its consequences on quality of sleep: an unexplored area","volume":"166","author":"L\u00e9ger","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2024.01.038_bib48","first-page":"415","article-title":"Sleep and allergic rhinitis","volume":"18","author":"Mullol","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13223-019-0391-9","article-title":"The impact of perennial allergic rhinitis with\/without allergic asthma on sleep, work and activity level","volume":"15","author":"Romano","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1081-1206(10)62434-9","article-title":"Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis","volume":"85","author":"Golden","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib51","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.anai.2013.05.020","article-title":"Sleep impairment and daytime sleepiness in patients with allergic rhinitis: the role of congestion and inflammation","volume":"111","author":"Thompson","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib52","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.01.038_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17270","article-title":"A\u00a0systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis","volume":"17","author":"Meadows","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jaip.2024.01.038_bib54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.13254","article-title":"Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: a systematic overview","volume":"73","author":"Asaria","year":"2018","journal-title":"Allergy"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T22:51:42Z","timestamp":1738795902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2213219824001405"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.01.038","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sublingual Tablet Immunotherapy Improves Quality of Life in Adults With Allergic Rhinoconjunctivitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.01.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}